Symbol | Marktkapitalisierung | Preis | Veränderung % | Volumen | Relatives Volumen | KGV | EPS-Verd. TTM | EPS-Verd. Wachstum TTM YoY | Dividendenrendite % TTM | Sektor | Analysten-Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
NOVO_BNOVO NORDISK B A/S | 3.992 T DKK | 878.7 DKK | −1.41% | 1.878 M | 0.98 | 47.20 | 18.62 DKK | +52.38% | 1.05% | Gesundheitstechnologie | Kauf |
GMABGENMAB A/S | 132.182 B DKK | 1972.0 DKK | −1.79% | 150.555 K | 1.41 | 29.86 | 66.03 DKK | −21.11% | 0.00% | Gesundheitstechnologie | Kauf |
ZEALZEALAND PHARMA A/S | 38.022 B DKK | 626.0 DKK | +2.45% | 341.047 K | 1.36 | — | −12.55 DKK | +49.12% | 0.00% | Gesundheitstechnologie | Kauf |
HLUN_BH. LUNDBECK A/S B | 26.211 B DKK | 33.00 DKK | 0.00% | 408.385 K | 0.84 | 14.31 | 2.31 DKK | +13.49% | 2.12% | Gesundheitstechnologie | Kauf |
HLUN_AH. LUNDBECK A/S A | 26.211 B DKK | 28.30 DKK | +0.18% | 88.709 K | 0.92 | 12.27 | 2.31 DKK | +19.49% | 2.48% | Gesundheitstechnologie | — |
BAVABAVARIAN NORDIC A/S | 11.784 B DKK | 149.50 DKK | −1.06% | 264.387 K | 0.64 | 7.82 | 19.12 DKK | — | 0.00% | Gesundheitstechnologie | Kauf |
ORPHAORPHAZYME A/S | 38.645 M DKK | 1074.8 DKK | −1.79% | 14 | 0.33 | — | −737.65 DKK | +95.89% | 0.00% | Gesundheitstechnologie | — |